Atea Pharmaceuticals Inc
Biotechnology
Healthcare
AVIR
85.16 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
2.93
52 week high
4.02
high
2.96
52 week low
0.00
low
2.87
growth
-20.98 %
previous Close
2.93
P/E ratio
market cap
320 M
div yield
0
usd
Jun 2025
qoq
revenue
0.00 %
net incoming
0.00 %
eps
0.00 %
0.00 %
eps surprise
100.00 %
net profit margin
0.00 %
0.00 %
operating incoming
0.00 %
net change in cash
0.00 %
cash on hand
0.00 %
cost of revenue
0.00 %
top top